Clear Communication

Research Rigor

Direct Partnership

KATIE CROSSLIN, PhD, CMPP™

A scientist first, a medical writer by craft

I started my career generating evidence as a health researcher. As a research scientist at Children’s Health in Dallas, I analyzed trauma registry data and mapped injury patterns that supported Texas booster seat legislation. As an Assistant Professor of Health Science at Texas Woman’s University, I led epidemiological studies on vaccine uptake and chronic disease severity, published eight first-author articles in five years, and reviewed regularly for seven peer-reviewed journals.

That grounding shapes how I write. When I develop a manuscript, I’m asking the questions a reviewer will ask: Do the results support the authors’ conclusions? Is the interpretation balanced, without overstating clinical significance? What are the limitations?

In 2016, I moved from academia into the industry. I developed manuscripts, abstracts, posters, slide decks and regulatory documents at Syneos Health, Ashfield and Evidera, working across rheumatology, oncology, rare disease, diabetes and cardiovascular medicine. I went on to serve as Scientific Director and Team Lead at Envision Pharma Group, followed by becoming a Senior Team Lead over a scientific services group at a global pharmaceutical company.

Along the way, I’ve managed publication timelines and budgets, led author meetings, selected target journals, and mentored medical writers. That experience helps me anticipate review bottlenecks, keep stakeholders aligned and move complex deliverables toward submission. Through my consulting practice, I bring that senior-level perspective directly to pharmaceutical teams.

Scientific rigor. Senior experience.

PhD, Community Health

Texas Woman’s University

MSEd, Community Health

Baylor University

BS, Biology

Baylor University

Certified Medical Publication Professional™

ISMPP CMPP

20 years

developing publications

Talent of the Quarter, 2026 (Q1)

Cella by Randstad Digital

HOW I WORK

A thoughtful, dependable partnership.

Understand your needs.

Partner with you to develop a clear path forward for your project.

Handle data with care and confidentiality.

Work fluently with GPP and ICMJE expectations.

Remain responsive and on time.

Selected Publications

Received acknowledgement as a medical writer

01

Alexandre A.F., Morga A., Thomas C., Krucien N., Tervonen T., et al. Preferences for Anaemia Treatment Attributes among Patients with Non-Dialysis-Dependent Chronic Kidney Disease. Adv Ther. 2023;40(2):641-657.

02

Mokgokong R., Schnabel R., Witt H., Miller R., Lee T.C. Performance of an electronic health record-based predictive model to identify patients with atrial fibrillation across countries. PLoS ONE. 2022;17(7): e0269867.

03

Faravardeh A., Akkina S., Villicana R., Guerra G., Moten M.A., et al. Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial. Ann Transplant. 2021;26:e929535.

04

Smolen J.S., Xie L., Jia B., Taylor P.C., Burmester G., et al. Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study. Rheumatology (Oxford). 2021;60(5):2256-2266.

05

Dörner T., Tanaka Y., Petri M.A., Smolen J.S., Wallace D.J., et al. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Lupus Sci Med. 2020;7(1):e000424.

06

Migdal A., Abrahamson M., Peters A., Vint V. Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets. Annals of Medicine. 2018;50:6, 453-460.

Selected Publications

Selected Publications That I Authored

01

Lanning, B., Golman, M., & Crosslin, K.L. (2017). Improving human papillomavirus vaccination uptake in college students: a socio-ecological perspective. American Journal of Health Education, 48(2), 116-128.

02

Amuta, A.O., Crosslin, K.L., Goodman, J., Barry, A.E. (2016). Impact of Type 2 Diabetes Threat Appraisal on Physical Activity and Nutrition Behaviors among Overweight and Obese College Students. American Journal of Health Behavior, 40(4), 396-404.

03

Amuta, A., Jacobs, W., Barry, A.E., Popoola, O., & Crosslin, K.L. (2016). Gender Differences in Type 2 Diabetes Risk Perception, Attitude and Protective Health Behaviors: A study of Overweight and Obese College Students. American Journal of Health Education, 47(5), 315-323.

04

Crosslin, K.L., Tsai, R., & Massey-Stokes, M. (2015). A Qualitative exploration of less acculturated Mexican mothers and their safety perceptions of medicines, cleaners, and herbs in the home. Journal of Immigrant and Minority Health, 18(2), 420-427.

05

Crosslin, K.L., & Tsai, R. (2016). Unintentional ingestion of cleaners and other substances among immigrant Mexicans: A qualitative study. Injury Prevention, 22(2), 140-143.

06

Crosslin, K.L., & Wiginton, K.L. (2011). Sex differences in disease severity among Systemic Lupus Erythematosus patients. Gender Medicine, 8, 365-371.

HOW I WORK

A thoughtful, dependable partnership

Understand your needs. I ask key questions to align on project goals, audience, scope, timelines, and deliverables.

Partner with you to develop a clear path forward for your project. Together, we’ll confirm priorities, roles, timelines, and next steps before the work begins.

Handle data with care and confidentiality, following applicable privacy requirements and established data-handling practices throughout the project.

Work fluently with GPP and ICMJE expectations to support transparent, ethical, and publication-ready medical communications.

Remain responsive and on time, providing clear updates, addressing questions promptly, and meeting agreed-upon deadlines throughout the project.

LET’S MOVE YOUR WORK FORWARD

Ready to Move Your Scientific Work Forward?

Share your project type, available data and target deadline, and I’ll help you determine the right scope and engagement model.